Buprenorphine And Naloxone
Product Images NDC 67296-1877

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Buprenorphine And Naloxone (NDC 67296-1877). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 2 mg/0.5 mg Carton Label (Image 01)

Packaging label for Buprenorphine and Naloxone Sublingual Film 2 mg/0.5 mg by Mylan Pharmaceuticals Inc. The label includes dosage instructions, storage information, and cautionary statements. It specifies a bottle containing 30 sublingual film pouches, with instructions to place films under the tongue or inside the cheek. The label features the product name prominently, along with the NDC 0378-8765-93 and the Mylan logo.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 4 mg/1 mg Carton Label (Image 02)

Packaging label for Buprenorphine and Naloxone Sublingual Film 4 mg/1 mg by Mylan Pharmaceuticals Inc. The label shows it contains 30 pouches, each with 1 sublingual film. Instructions for use, storage, and warnings are present. The label includes NDC 0378-8766-93 and barcode details.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 8 mg/2 mg Carton Label (Image 03)

Packaging label for Buprenorphine and Naloxone Sublingual Film 8 mg/2 mg by Mylan Pharmaceuticals. The label shows the product name, strength, dosage form, and manufacturer. It includes usage instructions, storage conditions, safety warnings for children, and a barcode. The design features blue, white, and black colors with the Mylan logo.*

FDA Label Image

Buprenorphine And Naloxone Sublingual Film 12 mg/3 mg Carton Label (Image 04)

Carton label for Buprenorphine and Naloxone Sublingual Film 12 mg/3 mg by Mylan Pharmaceuticals. The label includes dosage instructions, warnings about accidental ingestion, and administration methods. The packaging specifies it contains 30 pouches, each with one sublingual film, and displays several barcodes and a QR code. The label also shows the NDC 0378-8768-93 and is marked Rx only.*

FDA Label Image

Buprenorphine Hydrochloride Structrual Formula (Image 05)

Chemical structure of the active ingredient in Buprenorphine and Naloxone, depicting the molecular arrangement including multiple ring systems and functional groups. The image also indicates a hydrochloride (HCl) salt form association.*

FDA Label Image

Naloxone Hydrochloride Structural Formula (Image 06)

Chemical structure of Buprenorphine hydrochloride dihydrate showing the molecular arrangement with distinct chemical bonds, including a phenol group and a ketone group.*

FDA Label Image

Instructions For Use Figure 1 (Image 07)

An instructional illustration showing one hand holding a card with a barcode while the other hand uses scissors to cut across the barcode. The image depicts how to properly cut the barcode from a card, likely for product redemption or identification purposes.*

FDA Label Image

Instructions For Use Figure 2 (Image 08)

Black and white illustration showing an open mouth with a sublingual tablet placed under the tongue on the lower left side. The image depicts the administration route of a sublingual medication.*

FDA Label Image

Instructions For Use Figure 3 (Image 09)

Instructional drawings showing the placement of a buprenorphine and naloxone sublingual film inside the mouth. One image depicts placing the film under the tongue, and the other shows placing it against the inside of the cheek, illustrating proper administration sites for the medication.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.